Stay updated on Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page displays a new revision label from v3.2.0 to v3.3.2, with no changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the administrative banner about potential data currency due to government funding lapse. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe study record now displays the Results First Posted date (2025-04-29) and updated Enrollment (Actual) and Primary Completion dates.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference3%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element. Overall, no substantive changes to core content.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.